Adhera Therapeutics 10K 2010 Annual report | ATRX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abdominal, AC, Academy, ACLARA, advice, Advisor, advocacy, aerospace, affinity, Affordable, afforded, AICPA, alkylated, Alto, AMAX, Ampersand, Anderson, Annex, annum, Antagomir, APC, ArQule, Arthur, ASC, assumption, attended, attenuated, auditor, avenue, bacteria, banker, bankruptcy, Baxter, BayBio, benchmarking, Benitec, Beth, bill, Biochemistry, Biographical, Bioscience, bleeding, Boston, Brigham, bring, broadest, budget, Buffalo, burn, California, Cambridge, catenin, Chair, chairmen, channel, charitable, Chiang, choice, classical, clicking, Climax, coauthored, Cobra, colectomy, Coli, Colorado, colorectal, column, comfort, Concurrent, Conformationally, constipation, constitute, constituted, constituting, CoPharma, Corixa, counsel, CRN, cum, cure, cutting, Deal, Debiopharm, Debiopharn, defray, delegated, demonstratedin, Dendreon, diagnostic, diarrhea, disability, DNAi, Dynex, dysplastic, dysregulated, earliest, Eastern, eleven, elucidation, Empery, energy, engineered, engineering, Ensemble, entirety, EU, evenly, FAP, feedback, feel, FEI, fellowship, fifty, FinancialDisclosure, fluid, forfeit, forma, founder, fourteen, fraction, fractional, Francisco, gastric, Genuity, Georgetown, Germany, GP, Graduate, graduated, Gregory, Halle, harnessing, Harvard, Heart, hereditary, Hoe, hourly, Huntington, imbalance, inappropriate, incumbent, Indenture, insolvency, intestinal, intestine, irrevocable, Israel, itsTransKingdom, job, Kendall, KMR, Lane, laude, Li, lieu, linker, Lipitor, literacy, loading, locked, Los, lowest, LP, lump, MA, Magellan, magna, malignancy, malignant, marina, Martin, mechanism, mediator, merged, merging, metropolitan, microbiology, microRNA, Military, Moraga, mouth, multiplied, multiplying, Nanodyne, nanotechnology, Neurontin, newly, ninety, nominate, Nominating, noncompetitive, Northern, Novacept, NOVEX, nucleoside, nucleotide, Nuvelo, occasion, onset, opposed, orderly, orphan, ourtkRNAi, ovarian, overseeing, owed, palliative, Palo, pancreatic, PAREXEL, Parker, passed, pathway, payload, pecuniary, peer, Pennsylvania, Pentose, percentile, permissible, perpetual, Pharmaco, physiology, postdoctoral, PPACA, predefined, predominately, prepaid, Printed, pro, procure, Proliferation, ProNAi, properly, Purdue, purification, PV, PVIII, quotient, Radford, rare, ratification, RB, ready, recapitalization, recommend, recommended, reconciliation, region, regularly, relocation, residence, residency, retroactively, ribose, rigid, ring, Rosetta, Ryan, safer, salary, sampling, San, Seattle, sector, Sessler, shRNA, sixty, SNP, Sociology, solicit, solid, spent, Spiration, split, spouse, Stanford, stem, subscription, substance, superficial, survey, synthetic, Syracuse, tauRNAi, Taylor, Tech, teenage, TekCel, telecommunication, tenure, terrorism, thermal, ThermoBiostar, thetkrnai, thirty, Thursday, tkRNAi, Tomah, Topic, transcription, transformation, transkingdom, travel, turn, turnover, twenty, ulcerative, uncontrolled, undertaken, underwritten, undruggable, uneconomical, Union, unpaid, unusable, unused, vacation, verification, virtue, visiting, VITEX, VLST, vulnerable, VWAP, waived, waiver, Wall, war, Wednesday, West, wholly, writing

Removed: Allergy, antiviral, bank, Beckman, borrowing, Calando, caption, collaborate, competitor, composed, comprehensive, created, cumulative, cycle, defense, Dicer, doubtful, duty, elimination, fact, force, Galenea, hereof, hope, improved, infection, influenza, instrument, inventory, launch, leasehold, lot, minimal, MIT, nastech, NIH, notification, paper, Pharma, poor, principle, pulmonary, qualifying, quay, ranged, ranging, realizable, requisite, residual, respiratory, retail, shipped, stated, steven, suggested, Tacere, undergo, unrealized, urge, viral, warehousing


Name	State of Incorporation	Ownership
Cequent Pharmaceuticals, Inc.	Delaware	100%
MDRNA Research, Inc.	Delaware	100%
Atossa HealthCare, Inc.	Delaware	100%

Adhera Therapeutics (ATRX) 10-K2010 FY Annual report

Content analysis